Cargando…

P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Detalles Bibliográficos
Autores principales: van de Donk, N., Cortes-Selva, D., Casneuf, T., Vishwamitra, D., Stein, S., Perova, T., Ramos, E., Van Steenbergen, L., Boominathan, R., Lau, O., Davis, C., Banerjee, A., Stephenson, T., Uhlar, C., Kobos, R., Goldberg, J., Pei, L., Trancucci, D., Girgis, S., Lin, S.X.W., Wu, L.S., Moreau, P., Usmani, S., Bahlis, N.J., Verona, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171470/
http://dx.doi.org/10.1097/01.HS9.0000936256.84340.a7
_version_ 1785039423408177152
author van de Donk, N.
Cortes-Selva, D.
Casneuf, T.
Vishwamitra, D.
Stein, S.
Perova, T.
Ramos, E.
Van Steenbergen, L.
Boominathan, R.
Lau, O.
Davis, C.
Banerjee, A.
Stephenson, T.
Uhlar, C.
Kobos, R.
Goldberg, J.
Pei, L.
Trancucci, D.
Girgis, S.
Lin, S.X.W.
Wu, L.S.
Moreau, P.
Usmani, S.
Bahlis, N.J.
Verona, R.
author_facet van de Donk, N.
Cortes-Selva, D.
Casneuf, T.
Vishwamitra, D.
Stein, S.
Perova, T.
Ramos, E.
Van Steenbergen, L.
Boominathan, R.
Lau, O.
Davis, C.
Banerjee, A.
Stephenson, T.
Uhlar, C.
Kobos, R.
Goldberg, J.
Pei, L.
Trancucci, D.
Girgis, S.
Lin, S.X.W.
Wu, L.S.
Moreau, P.
Usmani, S.
Bahlis, N.J.
Verona, R.
author_sort van de Donk, N.
collection PubMed
description
format Online
Article
Text
id pubmed-10171470
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101714702023-05-11 P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) van de Donk, N. Cortes-Selva, D. Casneuf, T. Vishwamitra, D. Stein, S. Perova, T. Ramos, E. Van Steenbergen, L. Boominathan, R. Lau, O. Davis, C. Banerjee, A. Stephenson, T. Uhlar, C. Kobos, R. Goldberg, J. Pei, L. Trancucci, D. Girgis, S. Lin, S.X.W. Wu, L.S. Moreau, P. Usmani, S. Bahlis, N.J. Verona, R. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171470/ http://dx.doi.org/10.1097/01.HS9.0000936256.84340.a7 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster
van de Donk, N.
Cortes-Selva, D.
Casneuf, T.
Vishwamitra, D.
Stein, S.
Perova, T.
Ramos, E.
Van Steenbergen, L.
Boominathan, R.
Lau, O.
Davis, C.
Banerjee, A.
Stephenson, T.
Uhlar, C.
Kobos, R.
Goldberg, J.
Pei, L.
Trancucci, D.
Girgis, S.
Lin, S.X.W.
Wu, L.S.
Moreau, P.
Usmani, S.
Bahlis, N.J.
Verona, R.
P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_full P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_fullStr P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_full_unstemmed P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_short P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
title_sort p32 majestec-1: correlative analyses of teclistamab, a b-cell maturation antigen (bcma) x cd3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (rrmm)
topic Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171470/
http://dx.doi.org/10.1097/01.HS9.0000936256.84340.a7
work_keys_str_mv AT vandedonkn p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT cortesselvad p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT casneuft p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT vishwamitrad p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT steins p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT perovat p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT ramose p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT vansteenbergenl p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT boominathanr p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT lauo p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT davisc p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT banerjeea p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT stephensont p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT uhlarc p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT kobosr p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT goldbergj p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT peil p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT trancuccid p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT girgiss p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT linsxw p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT wuls p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT moreaup p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT usmanis p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT bahlisnj p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm
AT veronar p32majestec1correlativeanalysesofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm